Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
445680
vs
K
KOSPI 200
Over the past 12 months, Curiox BioSystems Co Ltd has underperformed KOSPI 200, delivering a return of -30% compared to KOSPI 200's +125% growth.
Stocks Performance
445680 vs KOSPI 200
Performance Gap
445680 vs KOSPI 200
Performance By Year
445680 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Curiox BioSystems Co Ltd
Glance View
Curiox BioSystems makes laboratory tools that help scientists prepare biological samples for testing. Its main products are automated systems and consumables for washing, staining, and handling cells and other delicate samples in research and clinical labs. The company’s equipment is designed to reduce manual sample-prep steps, which can save time and help make lab results more consistent. The company sells mainly to biotech and pharmaceutical companies, research labs, hospitals, and other life-science organizations that need reliable sample preparation for experiments and diagnostics. It makes money by selling its instruments and by supplying the consumables that work with those instruments, which creates repeat business after the initial equipment sale. That model ties customers into its installed base because the tools and disposable parts are designed to work together. What makes Curiox different is its role in the sample-preparation part of the lab workflow, not in the final test itself. It sits upstream of analysis, where small errors can affect the quality of downstream results. By focusing on gentler, more automated sample handling, the company aims to replace manual lab work with a more standardized process that fits both high-throughput research and clinical testing.